Migratory CD103+ cDC1s are one of the primary cell types capable of trafficking intact tumor-associated antigens from the tumor to the TdLN via a CCR7-dependent mechanism to initiate CD8+ T-cell priming (12). Here, CCR7 is linked to neoplasm.